Skip to main content
. 2020 Jun 16;58(5):305–313. doi: 10.1136/jmedgenet-2019-106739

Figure 2.

Figure 2

Estimated cumulative risk (%) of ovarian cancer in a PALB2 deleterious variant carrier compared with population risks for England and Wales, 2016.